Available to sourceHuman Prescription DrugGastrointestinal

Sodium Chloride

9 mg/mL · Injection

By Hikma Pharmaceuticals USA Inc.

NDC: 0641-0497
Route: Intramuscular; Intravenous; Subcutaneous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

25 VIAL in 1 CARTON (0641-0497-25) / 2 mL in 1 VIAL (0641-0497-17)NDC 0641-0497-25Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.